October 16, 2019
To whom it may concern:
Company name: FRONTEO, Inc.
Representative: Masahiro Morimoto,
Chief Executive Officer and President
(Tokyo Stock Exchange Code: 2158)
(NASDAQ: FTEO)
Contact: Tomohiro Uesugi, Director, Chief Financial Officer,
Chief Administrative Officer
Telephone: +81-3-5463-6344
Announcement of Completion of Absorption-Type Merger with FRONTEO Healthcare, Inc.
As announced in the “Notice Regarding FRONTEO’s Absorption-Type Merger of FRONTEO Healthcare, Inc.”, dated August 29, 2019, FRONTEO, Inc., as surviving company, today completed the merger of its wholly-owned consolidated subsidiary, FRONTEO Healthcare, Inc. (the merged company).